Illumina Partnerships
Collaborating to Advance Genomics
As a global leader in genomics, we continually strive to offer solutions that are not only innovative, but also accessible and always reliable. Illumina partnerships help advance genomics in numerous ways, from expanding access to next-generation sequencing (NGS) to pioneering new applications and technologies, providing funding for innovative startups, and more.
Featured Pharmaceutical & Biotech Partnerships
Some of our existing partnerships include:
Roche
Illumina and Roche partner to broaden the adoption of distributable next-generation sequencing-based testing in oncology.
Read Press ReleaseBristol-Myers Squibb, Merck, Kura, & Myriad
Illumina forms multiple partnerships to develop precision oncology solutions.
Read Press ReleaseLoxo Oncology
Illumina and Loxo Oncology partner to develop next-generation sequencing-based pan-cancer companion diagnostics.
Read Press ReleaseAdditional Partnerships
Discover more Illumina partnerships and collaborations designed to advance access to groundbreaking genomics solutions.
IIllumina & GenoScreen Partner on Multidrug-Resistant Tuberculosis Testing
The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB.
Illumina & QIAGEN Partner on Sequencing-Based Diagnostic Tests
The partnership focuses on commercializing oncology In Vitro Diagnostc (IVD) kits to support patient management and may expand to other clinical fields in the future.
Illumina & Microba Life Sciences Partner to Accelerate Microbiome Research
The partnership brings together revolutionary Illumina NGS tools and a high-quality proprietary gut microbiome analysis platform from Microba to rapidly process large volumes of metagenomic data.
Amazon Web Services (AWS) Partnership with Illumina
The partnership supports genomic analysis customers with innovative and secure, cloud-based data processing, management, and storage.
Technology Development and Integrations
We strive to offer the best possible technologies and solutions to our customers. By integrating our technology with other best-in-class solutions, we aim to improve workflows, support groundbreaking research, and continue advancing genomics.
Learn More
Startup Funding for Genomics Companies
With mentorship, financial support, and access to sequencers and reagents, the Illumina Accelerator is helping genomics startups launch so we can unlock the power of the genome—together.
Illumina for StartupsGenomics News
When CGP uncovers potential hereditary cancer risk
A large US community hospital system examines reporting and follow-up for germline variants in advanced cancer patients
Read article
Efficient cloud data analysis for COPD multiomics project
Researchers at Okayama University in Japan use Illumina Connected Analytics with DRAGEN pipelines for analyzing whole-genome, exome, transcriptome, and metagenome data
Read Interview
Early access users rave about Illumina’s new MiSeq i100 Series
Laboratory managers on three continents praise the sequencers’ ease of use, speed, and room-temperature reagent shipping and storage
Read article